MedPath

Intra-articular Corticosteroid Injection Compared With Single-Shot Hyaluronic Acid for Treatment of Osteoarthritis Knee

Phase 4
Completed
Conditions
Knee Osteoarthritis
Interventions
Drug: Corticosteroid
Registration Number
NCT01874574
Lead Sponsor
Thammasat University
Brief Summary

Corticosteroid and Hylan G-F 20 are both effective in improving pain and function of osteoarthritic knee patients.

Detailed Description

Corticosteroid and Hylan G-F 20 are both effective in improving pain and function of osteoarthritic knee patients up to 6 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Clinical diagnosis of knee OA
  • Knee pain for most days of the prior month
  • Radiographic evidence consistent with knee OA
  • Aged between 40 and 80 years old
Exclusion Criteria
  • Lumbar spondylosis
  • Gross deformity of the knee
  • Co-existent inflammatory or crystal arthritis
  • Prior knee surgery
  • Injury to the knee in the preceding 6 months
  • Any intra-articular injection in the preceding 3 months
  • Pregnant or Lactating
  • Current infection in the affected knee
  • Inability to provide informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Corticosteroid (Triamcinolone acetonide)CorticosteroidIntra-articular injection of 1 mL of 40 mg Triamcinolone acetonide plus 5 mL of 1% xylocaine with adrenaline injected at the knee by single shot
Single shot Hylan G-F 20 (Synvisc)Hylan G-F 20Intra-articular injection of the Single shot 6 mL of Hylan G-F 20 (Synvisc)
Primary Outcome Measures
NameTimeMethod
WOMAC Score6 months

Change from Baseline in WOMAC score at 6 months

Secondary Outcome Measures
NameTimeMethod
Visual Analogue Scale(VAS)6 months

Change from Baseline in VAS score at 6 months

Trial Locations

Locations (1)

Thammasat University Hospital, Thammasat University

🇹🇭

Prathumthani, Thailand

© Copyright 2025. All Rights Reserved by MedPath